However, subsequent colocalization analysis revealed limited evidence for association between TYRP1 and CM, indicating that while TYRP1 is a therapeutic target for CM, its relationship with the disease is not driven by shared causal genetic variants. The gene discussed is TYRP1; the disease is cutaneous mastocytosis.